Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000581620 | SCV000688249 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000581620 | SCV001172677 | likely benign | Hereditary cancer-predisposing syndrome | 2018-06-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001393070 | SCV001594723 | likely benign | Juvenile polyposis syndrome | 2024-12-25 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001393070 | SCV004838526 | likely benign | Juvenile polyposis syndrome | 2023-02-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004586769 | SCV005077606 | likely benign | not specified | 2024-04-18 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV001393070 | SCV005407436 | benign | Juvenile polyposis syndrome | 2024-08-08 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |